Table 2.
The information of nine prognostic mRNAs importantly associated with metastasis and overall survival in patients with lung adenocarcinoma
| mRNA | Ensemble ID | Location | B (cox) | HR (95% CIs) | P |
|---|---|---|---|---|---|
| HMMR | ENSG00000072571 | Chr5: 163,460,203–163,491,945 | 0.2551 | 1.3060 | 0.00025 |
| B4GALT1 | ENSG00000086062 | Chr9: 33,104,082–33,167,356 | 0.2160 | 1.2411 | 0.07121 |
| SLC16A3 | ENSG00000141526 | Chr17: 82,228,397–82,261,129 | − 0.1570 | 0.8547 | 0.13969 |
| ANGPTL4 | ENSG00000167772 | Chr19: 8,363,289–8,374,373 | 0.1238 | 1.1318 | 0.01137 |
| EXT1 | ENSG00000182197 | Chr8: 117,794,490–118,111,853 | 0.2381 | 1.2688 | 0.04074 |
| GPC1 | ENSG00000063660 | Chr2: 240,435,671–240,468,078 | 0.1027 | 1.1082 | 0.15791 |
| RBCK1 | ENSG00000125826 | Chr20: 407,498–430,966 | 0.1820 | 1.1996 | 0.12534 |
| SOD1 | ENSG00000142168 | Chr21: 31,659,622–31,668,931 | 0.1874 | 1.2061 | 0.11555 |
| AGRN | ENSG00000188157 | Chr1: 1,020,123–1,056,118 | 0.2226 | 1.2494 | 0.02277 |